User contributions
From 2009.igem.org
(Latest | Earliest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)
- 02:03, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Team
- 02:02, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Project Management
- 02:00, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Gallery
- 01:58, 22 October 2009 (diff | hist) N File:Bibsette2.png (top)
- 01:57, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Biologie Synthetique (→Ethique)
- 01:56, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Biologie Synthetique (→Ethique)
- 01:55, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Biobricks
- 01:53, 22 October 2009 (diff | hist) N File:LegoPiece2.png (top)
- 01:17, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Biologie Synthetique (→Sondage)
- 01:16, 22 October 2009 (diff | hist) N File:Légende fr.png (top)
- 01:15, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Biologie Synthetique (→Sondage)
- 00:56, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Ethic (→Survey)
- 00:53, 22 October 2009 (diff | hist) N File:Légende en.png (top)
- 00:53, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Ethic (→Survey)
- 00:52, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Ethic (→Survey)
- 00:51, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Ethic (→Survey)
- 00:50, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Ethic (→Survey)
- 00:48, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Ethic (→Survey)
- 00:44, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Ethic (→Survey)
- 00:42, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Ethic (→Survey)
- 00:35, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Ethic (→Survey)
- 00:16, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Ethic (→Survey)
- 00:14, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Ethic (→Survey)
- 00:12, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Modeling du traitement (→Evolution en simultanée du DVS et d'une tumeur)
- 00:08, 22 October 2009 (diff | hist) N File:EqFinaleEN.jpg (top)
- 00:04, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Ethic (→Survey)
- 00:00, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Ethic (→Survey)
- 23:59, 21 October 2009 (diff | hist) N File:Sondage gouvernance mondiale.png (top)
- 23:58, 21 October 2009 (diff | hist) N File:Sondage maitriser la propagation des systèmes construits.png (top)
- 23:58, 21 October 2009 (diff | hist) N File:Sondage peut-on contrôler le vivant.png (top)
- 23:57, 21 October 2009 (diff | hist) N File:Sondage divergence de l'évolution.png (top)
- 23:56, 21 October 2009 (diff | hist) N File:Sondage application thérapeutique.png (top)
- 23:56, 21 October 2009 (diff | hist) N File:Sondage brevetabilité d'un OGS.png (top)
- 23:55, 21 October 2009 (diff | hist) N File:Sondage breve = ralentissement innovation.png (top)
- 23:55, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Ethic (→Survey)
- 23:48, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Ethic (→Survey)
- 23:47, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Ethic (→Survey)
- 23:46, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Ethic (→Survey)
- 23:23, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Treatement modeling (→Cinquième étape : L’internalisation du vecteur cellulaire)
- 23:20, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Treatement modeling (→The diffusion through the walls of blood vessels)
- 23:17, 21 October 2009 (diff | hist) m Team:SupBiotech-Paris/Modeling du traitement (→Zone de dispersion du phage)
- 23:07, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Treatement modeling (→The phage propagation in the bloodstream)
- 23:07, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Treatement modeling (→Fourth step : The cell vector dispersion)
- 22:50, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Treatement modeling (→Fourth step : The cell vector dispersion)
- 21:58, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Modeling du traitement
- 21:52, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Treatement modeling (→Modelling of DVS efficacy on a lung tumour)
- 21:51, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Treatement modeling
- 21:38, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Treatement modeling (→Simulation de traitement)
- 21:37, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Treatement modeling
- 21:34, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Sûreté (top)
(Latest | Earliest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)